Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Galectin Therapeutics Inc. logo

Galectin Therapeutics Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

1.95
 
USD
  
-0.01
  
(-0.51%)
Optionable: Yes  Market Cap: 124 M  90-day average vol: 54,698

Previous close: 1.96  Open: 1.95  Bid: 1.94  Ask: 2.01
52 week range    
1.02   
   2.47
Peers   
MEIP / 
NBIX / 
NAVB / 
Last updated: Friday 1st December 2023

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

GALT Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccretionOnPreferredStock229000.0229000.0229000.0173000.0
AccruedPreferredStockDividends10 M943000.0868000.0741000.01 M1 M7 M137000.0171000.097000.0
Basic EPS from continuing operations-0.41
Basic EPS total-0.41-0.52-0.65
Basic weighted shares outstanding17 M22 M24 M29 M36 M39 M52 M57 M59 M59 M
Diluted EPS total-1.3-0.78-0.88-0.76-0.49-0.38-0.39-0.41-0.52-0.65
Diluted normalized net income/share-0.39-0.41
Diluted weighted shares outstanding9 M20 M23 M28 M33 M37 M52 M57 M59 M59 M
Earnings from equity interest-400000.0
EarningsFromEquityInterestNetOfTax-400000.0
GainOnSaleOfSecurity138000.0557000.0
GeneralAndAdministrativeExpense6 M7 M7 M6 M5 M7 M6 M5 M6 M7 M
Income before tax-12 M-16 M-20 M-21 M-16 M-14 M-13 M-23 M-31 M-39 M
Interest income16000.042000.0104000.045000.024000.038000.0231000.066000.03000.052000.0
InterestExpenseNonOperating12000.0336000.087000.087000.0489000.01 M
MiscOtherSpecialCharges-138000.0-557000.0
Net income from total operations-12 M-16 M-20 M-21 M-16 M-14 M-13 M-23 M-31 M-39 M
NetIncomeCommonStockholders-22 M-17 M-21 M-22 M-17 M-15 M-20 M-24 M-31 M-39 M
NetIncomeContinuousOperations-12 M-16 M-20 M-21 M-16 M-14 M-13 M-23 M-31 M-39 M
NetNonOperatingInterestIncomeExpense16000.042000.0104000.045000.012000.0-298000.0144000.0-21000.0-486000.0-981000.0
Operating income-12 M-15 M-20 M-21 M-16 M-14 M-13 M-23 M-30 M-38 M
Operating income before depreciation (EBITDA)-12 M-16 M-20 M-21 M-16 M-14 M-13 M-23 M-30 M-38 M
OperatingExpense-12 M-15 M-20 M-21 M-16 M-14 M13 M23 M-30 M-38 M
Other income net400000.0-138000.0-557000.0
OtherGandA6 M7 M7 M6 M5 M7 M6 M5 M6 M7 M
OtherunderPreferredStockDividend10 M1 M1 M914000.01 M1 M7 M137000.0171000.097000.0
PreferredStockDividends10 M1 M1 M914000.01 M1 M7 M137000.0171000.097000.0
RentAndLandingFees6 M7 M7 M6 M5 M7 M6 M7 M
Research & development expense6 M8 M13 M15 M12 M6 M7 M18 M24 M32 M
ResearchExpense6 M8 M13 M15 M12 M6 M7 M18 M24 M32 M
SalariesAndWages-4 M-4 M-4 M-2 M-2 M-2 M-3 M
Selling Gen & administrative expense6 M7 M7 M6 M5 M7 M6 M5 M6 M7 M
Total Income available for interest expense (EBIT)-12 M-16 M-20 M-21 M-16 M-14 M-13 M-23 M-30 M-38 M
Total common shares outstanding22 M24 M29 M34 M38 M46 M57 M57 M59 M59 M
Total net income-12 M-16 M-20 M-21 M-16 M-14 M-13 M-23 M-31 M-39 M
Total ordinary shares60 M60 M60 M60 M60 M60 M60 M60 M60 M60 M
TotalExpenses-12 M-15 M-20 M-21 M-16 M-14 M13 M23 M-30 M-38 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today